⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

STARHEALTH - Fundamental Analysis: Financial Health & Valuation

← Back to List

⭐ Rating: 4

Last Updated Time : 02 Aug 26, 07:07 pm

Key Parameters

⭐ Fundamental Rating: 4.0

Stock CodeSTARHEALTH
Market Cap35,449 Cr.
Current Price601 ₹
High / Low625 ₹
Stock P/E42.0
Book Value0.00 ₹
Dividend Yield0.00 %
ROCE8.57 %
ROE6.70 %
Face Value10.0 ₹
DMA 50567 ₹
DMA 200510 ₹
Chg in FII Hold0.98 %
Chg in DII Hold-0.90 %
PAT Qtr550 Cr.
PAT Prev Qtr111 Cr.
RSI58.7
MACD8.44
Volume6,25,069
Avg Vol 1Wk12,93,429
Low price417 ₹
High price625 ₹
PEG Ratio-12.2
52w Index88.5 %
Qtr Profit Var25.5 %
EPS14.4 ₹
Industry PE39.6

✅ Positive

Star Health demonstrates robust revenue growth and a significant surge in profitability, driven by strong underwriting performance highlighted in the Q1 FY27 results. The company’s aggressive expansion strategy appears to be paying off, reflected in increased investor confidence.

⚠️ Limitation

Despite impressive short-term gains, the high P/E ratio suggests the stock is potentially overvalued and susceptible to market volatility given current valuations within the insurance sector. High debt ratios (currently unknown from provided data) present a potential risk if interest rates rise.

📉 Company Negative News

Recent news indicates a decrease in DII holdings, signaling reduced domestic investor confidence which could impact future growth momentum. The reported increase in PAT is primarily due to exceptional underwriting profits, raising questions about sustainability going forward.

📈 Company Positive News

Star Health’s Q1 FY27 results showcased a 44% year-on-year increase in profit and a sharp rise in underwriting profit, reflecting positive market performance. The availability of an earnings call audio recording allows for deeper analysis and investor engagement.

🏭 Industry

The insurance sector is currently experiencing strong growth driven by rising health awareness, increasing disposable incomes, and supportive government regulations. However, the industry faces challenges including regulatory changes, competition from private players, and macroeconomic uncertainties which could impact profitability and market share.

🧾 Conclusion

We recommend an entry zone between 560 ₹ and 580 ₹, targeting a potential upside of 10-15% based on current growth metrics. Long-term holding guidance would be to maintain a position through economic cycles, focusing on the company's strong brand reputation and expanding product portfolio – consider a sell strategy if debt ratios increase substantially. The stock presents a moderate risk/reward opportunity within a competitive industry.

Technical Analysis
Fundamental Analysis

NIFTY 50 · Fundamental

NEXT 50 · Fundamental

MIDCAP · Fundamental

SMALLCAP · Fundamental